Table 7.
1. Understand the mechanisms underlying adaptive vs. maladaptive RV adaptation to pulmonary vascular load, including role of fibrosis, angiogenesis, metabolic shifts |
2. Develop a series of plasma and/or imaging biomarkers (by echocardiography and CMR) that could be used to accurately evaluate RV function, perfusion, and RV–PA coupling and as endpoints in clinical trials |
3. Develop and validate or improve on current animal models of RV dysfunction in the setting of increased pulmonary vascular load |
4. Develop therapies aimed at targeting RV myocardial contractility (e.g., calcium-sensitizing agents targeting sarcoplasmic reticulum and/or sarcomere function) |
Definition of abbreviations: CMR = cardiac magnetic resonance imaging; PA = pulmonary artery; RV = right ventricular.
The list was generated by surveying working group members to identify their top five priorities. The most commonly mentioned topics and themes are included in the table.